Anda di halaman 1dari 6

AAK – Fats closer to mothers milk

AAK – The preferred partner in fats for Infant Nutrition

Products tailored for your needs Quality and Food safety


AAK offers a complete range of oils and fats AAK’s quality comprises the entire product
for infant nutrition. As examples can be chain – from raw material to finished prod-
mentioned: InFat – the highly refined uct. All of AAK’s production units are certi-
fat used in infant nutrition in order fied according to international standard’s.
to reduce constipation as one of Our approach to food safety is proactive
many advantages. The Akonino and preventive and covers the whole supply
range consists of blends with chain. A detailed HACCP plan is in operation
a specific fatty acid profile in our plants. We have defined our internal
tailored to the customer standard of contaminants, which in many
needs. cases goes beyond legal requirements for
potential hazardous contaminants.

Breast milk – the golden standard


The composition of breast milk is such that
it supplies the energy and components nec-
essary for growth and development of the
baby. The main components are: lactose,
fats and proteins. In addition to this it is a
source of minor components that are es-
sential for the healthy development of the
baby.
The fatty acid composition of breast milk
is influenced by a number of factors. It
changes during the breastfeeding period,
but it also depends on the time of day and
the eating habits of the mother. A typical
fatty acid composition can be found on
page 2

ß-palmitate
The triglyceride molecule of breast milk fat
has a specific composition (the same in hu-
mans all over the world), with a saturated
palmitic fatty acid (C16:0) in the central,
(sn-2 or ß) position and mainly unsaturated
fatty acids (C18:1) in the outer (sn-1,3 or α)
positions in the triglyceride. A glyceride with
palmitic fatty acid in the ß position is called
ß-palmitate.
The benefits of this triglycerid is explained
more in detail on page 5-6.

Fats in Infant Nutrition


Energy
Essential fatty acids
ß-palmitate

Infant Nutrition
2
Akonino – tailor made blends – AAK takes responsibility

Breast milk – the reference level of 1-2 % of linolenic acid (18:3) and a composition very close to that of breast
The reference for infant formula is breast part of the linoleic (18:2). milk. In this blend the linolenic acid is sup-
milk. An important aim is therefore to mimic In most cases at least one more liquid oil plied by rapeseed oil. Akonino NR is a simi-
the fat composition of human breast milk. is needed to provide the desired levels of lar blend where the linolenic acid comes
To achieve this, a number of different oils linoleic and oleic acid. from soyabean oil instead.
needs to be blended. Akonino SC is a blend comprising MCT
Akonino range oils, which are used in special formulas
Specified fat composition Most Akonino products are tailor made in for preterm infants. MCT oils are based on
A tailor made blend for an infant formula cooperation with the customer, some ex- short chain fatty acids (C8, C10) and as
may comprise up to five components of amples of standard products are described such are appreciated as an efficient source
specified proportions, in order to come as below. of energy.
close as possible to the fat composition in Akonino NS is a typical example of a
breast milk. blend for a standard infant formula, with
Different oils contribute with different
fatty acids providing the total composition
to be in line with the specification. AAK can Fatty acid composition of some typical Akonino products
provide a wide range of oils to fulfill any re-
Fatty acid Breast
quirement on composition.
profile (%) milk Akonino NS Akonino NR Akonino SC InFat 194D

Saturated fat from palm and laurics C8 0.6 0.5 2.2 30 0.8
Palm oil provides palmitic acid, which is the
predominant saturated fatty acid. To reach C10 1 0.5 1.8 20 0.8
the level of 20-25 % found in breast milk,
40-50 % palm oil or palm olein is required. C12 6.2 6 14.7 4.5 11
To get even closer to breast milk, palm oil
should be replaced by InFat, the product C14 7.8 2.5 5.9 1.5 4
described in pages 5-6.
In addition, coconut or palmkernel oil is C16 25 23 22.5 4.2 19
needed to provide the shorter-chain fatty
C18:0 8.7 3 3.7 1.4 4
acids.

C18:1 35.0 42 29.5 14.5 40


Essential fatty acids
Furthermore, the formula needs to contain
C18:2 11.0 19 15.6 19.5 18
sufficient essential fatty acids. 10-20 %
rapeseed or soyabean oil delivers the target
C18:3 1.2 2 1.5 2.8 2

Infant Nutrition
3
Akonino – tailor made blends – AAK takes responsibility

Guaranteed specification
After agreeing on a specification for the
complete blend, AAK will take the responsi-
bility to ensure that the specification is met
for each delivery. This saves the extra work
for the producer, who has to optimize the
composition depending on variations in the
raw materials. When buying a tailor made
Akonino blend, this optimization is handled
by AAK.

Application of Akonino
There is a strong regulation, regarding in-
fant formulae. As this is the only processed
food satisfying the needs of a growing baby.
It varies between different countries hereby
illustrated by part of the EC regulation.

Infant formulae can be dived in a number


of different segments, for example:
Starter formulae for the age of
0 to 6 months
Follow up formulae for the age of
5 to 12 months

The formulae is composed in different ways


in order to best suit the growing baby.

Illustration of the composition of different


formulas:

Starter Follow up
formula formula

Fat 24 % 20 % EC-directive

According to the EC directive 2006/141/EC fats for use in both starter and
Protein 11 % 11 %
follow up formulas have to comply with the following points:
Fat content of reconstituted product between 1.05 and 1.4 g/100 kJ
Carbohydrates 50 % 56 %
For allergenic reason the use of sesame and cottonseed oil is not allowed
The sum of Lauric acid (C12) and Myristic acid (C14): maximum 20 %
Akoninos are designed to fulfill the EC leg-
islation and can thereby be applied to the Content of α-linolenic acid: minimal 12 mg/100kJ
formula in the concentration of 24 % in a Linoleic acid: between 70-285 mg/100 kJ
starter formula and 20 % in a follow on for- Ratio between linoleic and α-linolenic: minimal 5 and maximal 15
mula. Trans fatty acids: maximum 3 % of total fat content
Erucic acid: maximum 1 % of total fat content

Infant Nutrition
4
InFat – closer to mother’s milk

Nothing can completely replace the


unique properties of mother’s milk, as it
contains everything a growing baby needs.
However, there are occasions when moth-
ers cannot breastfed, which is why alter-
natives are provided by the infant formula
industry. Advanced Lipids, a joint venture
between AAK and Enzymotec, supplies
optimal oil compositions mimicking the
composition of mother’s milk fat.

The main challenge for infant formula pro-


ducers is to develop a formula as close as
possible to the gold standard of mother’s
milk.
Over the years proteins, carbohydrates,
minerals, vitamins and probiotics have
been fine tuned and added to current in-
fant formula. It has been known for some
time that a specific fat is required to mimic
mother’s milk fat, but until recently only InFat composition
Supply of InFat
limited amounts were commercially avail- A structured triglyceride resembling moth-
InFat can be tailored to individual customer
able. With the opening of a new dedicated er’s milk fat is obtained through a unique
requirements, with all products in the range
production facility at AAK in Sweden, InFat enzymatic process in which the triglycerides
containing a high level of sn-2 palmitic
can be supplied in significant quantities from a vegetable – typically palm-based
acid.
and a growing number of customers are – fat are rearranged (see Figure 1). InFat
In most cases the fine tuning of the fatty
appreciating the benefits of a composition is based purely on vegetable oils. Clinical
acid composition, sn-2 palmitic and antioxi-
close to mother’s milk fat, with high quality studies show that when structured triglycer-
dants is done in cooperation with the cus-
and affordable price. ides are introduced in infant formula, both
tomer.
energy and calcium uptake, and reduced
InFat is currently used around the world,
Mother’s milk composition constipation, are similar to those of mother’s
but mainly in Europe and Asia.
Around 50 % of the calories in human milk, compared to standard vegetable fat
breast milk are supplied to the baby as fat.
Application of InFat
Human milk fat has a specific composition
Figure 1. The InFat Solution InFat is applied as the major fat in the infant
(the same in humans all over the world),
milk formula, ie around 24 % is added into
with a saturated palmitic fatty acid (C16:0) Traditional
Mother’s milk fat
infant milk fat a starter formula, see page 4.
in the central position and mainly unsatu- and InFat
As InFat can be tailored to different cus-
rated fatty acids (C18:1) in the outer posi- P O sn-1
tomer needs there is always an Infat prod-
tions in the triglyceride (see Figure 1).
O Enzymatic process P sn-2 (ß) uct suitable for Your needs!

Standard fat for infant formula P O sn-3

In standard infant formula, vegetable fat


has been used to fulfil the need for fat.
However, in vegetable fat the palmitic acid
Clinical studies in preterm and term infants, as well as preclinical animal model
is predominantly located in the outer posi- studies, show that beta-palmitate results in:
tions in the triglyceride and the unsaturated
Reduced stool hardness
fatty acids in the central position – the very
opposite to mother’s milk fat. Reduced calcium soaps formation
This is believed to be why infant formu- Increased calcium absorption
la-fed infants tend to show problems with Larger skeletal mineral deposition
energy and calcium uptake and increased Reduced excretion of saturated fatty (mainly palmitic) acids
constipation.

Infant Nutrition
5
InFat in new clinical study, presented at ESPGHAN

Advanced Lipids presented a poster at the ESPGHAN Meeting in Sorrento May 2011

New clinical studies Society for Paediatric Gastroenterology, Hepa- the clinical study when it is officially pub-
In 2010, new clinical studies demonstrating togology and Nutrition) end of May 2011. lished.
the effect of InFat in term babies had been The clinical study is right now under pre- Advanced Lipids has already started
concluded by Enzymotec. review before it will be published in scien- more clinical studies based on InFat, so you
Preliminary results were presented at the tific journals. can expect more interesting new findings in
ESPGHAN annual meeting (The European You will hear more about the outcome of the coming years.

Advanced Lipids
Combining Enzymotec and AAK strengths Enzymotec
Delivering Lipids
Advanced Lipids is a joint venture be-
tween Enzymotec, a global biotech com- + Worldwide expert in lipids + Worldwide expert in lipids
pany that develops and manufactures lip- technology technology
id-based bio-functional and nutraceutical + Global leader in fats for infant + Proven capabilities in supplying
ingredients; and AAK, the world’s leading nutrition innovative lipidbased, biofunctio-
nal ingredients and final products
producer of vegetable fats and oils for the + Global supplier of tailor-made
oils for infant formula producers + High standard clinical trials
infant formula industry. Advanced Lipids
provides a unique service package to our + State of the art production + Global business development
facilities
customers, thru combining Enzymotec’s + Intellectual property
+ High level of product quality
clinical R&D and expertise in lipid tech- and food safety + Regulatory expertise
nologies with AAK’s international strength
in food safety, production and logistics.

Advanced Lipids continuously invests in InFat Production Facility factory designed for continuous operation,
InFat clinical research and owns several The InFat production plant is located in the equipped with the latest technology for the
patents and patents pending in the area of AAK facility in Karlshamn, Sweden. The enzymatic production of structured triglyc-
infant nutrition. plant is a state of the art fully automated erides of the type found in mother’s milk.

AAK – Wherever you are For more information:


Our head office is in Malmö, Sweden, and we have production facilities in Denmark, Mexico, Infant.nutrition@aak.com
the Netherlands, Great Britain, Sweden, Uruguay and USA. So no matter where you are in the Telephone: +46 454 82000
world, you’re within reach of AAK, the first choice for value-added vegetable oil solutions.

Anda mungkin juga menyukai